Gulf Dyspnea Implantable Cardioverter-Defibrillator Registry (Gulf Dyspnea). This is an investigator-initiated study endorsed by the Gulf Heart Association and the Gulf Heart Rhythm Society and partially funded by Medtronic.
Gulf Dyspnea is the first multicenter multinational study of the characteristics and outcomes of patients receiving ICDs in the Arabian Gulf. While the efficacy of ICDs in high-risk patients has been well established in clinical trials